<DOC>
	<DOCNO>NCT01535872</DOCNO>
	<brief_summary>The aim study show solid evidence efficacy DHEA improve success rate in-vitro fertilization ( IVF ) patient face poor ovarian reserve .</brief_summary>
	<brief_title>Study Dehydroepiandrosterone Treatment Poor Responders In Vitro Fertilization Patients</brief_title>
	<detailed_description>Poor responder IVF treatment occur 5-24 % in-vitro fertilisation ( IVF ) cycle , result cancellation cycle translate low pregnancy rate . Current intervention base upon use different stimulation regimen address fundamental underlying physiological basis follicular recruitment development . The over-riding objective proposal devise novel therapeutic approach treatment poor responder IVF treatment dietary supplementation Dehydroepiandrosterone ( DHEA ) . The investigator hypothesise DHEA supplementation lead improvement ovarian steroidogenesis poor responder , lead improve IVF outcome . Specifically , investigator aim 1 . Conduct prospective randomise control trial ( RCT ) effect DHEA supplementation woman poor responder IVF treatment . 2 . Investigate effect DHEA supplementation ovarian steroidogenesis biochemical ultrasonographic marker ovarian reserve .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>All woman meet one two follow Bologna criterion poor responder : abnormal ovarian reserve test ( AMH &lt; 1.0 ng/mL FSH &gt; 10 IU/L ) , few 4 oocyte retrieve few 4 follicle observe previous IVF stimulation cycle either standard long antagonist protocol Where inform consent obtain Previous current DHEA supplementation Previous current use corticosteroid Major systemic illness Allergy DHEA</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>